Prophylactic Antitubercular Therapy Is Associated With Accelerated Disease Progression in Patients With Crohn's Disease Receiving Anti-TNF Therapy: A Retrospective Multicenter Study

Liu, F; Tang, J; Ye, LN; Tan, JY; Qiu, Y; Hu, F; He, JS; Chen, BL; He, Y; Zeng, ZR; Mao, R; Cao, Q; Gao, X; Chen, MH

Chen, MH (通讯作者)，Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Peoples R China.;Gao, X (通讯作者)，Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou, Peoples R China.;Cao, Q (通讯作者)，Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gastroenterol, Hangzhou, Peoples R China.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022; 13 (6):

Abstract

INTRODUCTION: Prophylactic antitubercular therapy (ATT) is widely prescribed in patients with Crohn's disease (CD) receiving antitumor necrosis factor......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索